Von Willebrand Disease (VWD) research hub
6 indexed studies · 6 currently recruiting
- recruitingPHASE2
HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB
This study is looking into a new medicine, ALN-6400, for women and teenage girls who have Von Willebrand Disease (VWD) and heavy periods (Heavy Menstrual Bleeding or HMB). Researchers want to see if the medicine is safe, how well it works, and how it affects the body.
United States · Netherlands · Sweden - recruitingPHASE3
Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
This study is looking into a new medication called VGA039 for people with Von Willebrand Disease (VWD). It's a Phase 3 trial, meaning it's a later stage of research, testing if this medicine can safely and effectively reduce bleeding when given as an injection under the skin.
United States · Australia · Austria - recruiting
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
This study is gathering information on how Von Willebrand Disease (VWD) affects people's lives in the UK. Researchers want to understand bleeding episodes, treatments, and quality of life to help improve future care for VWD.
United States · Australia · United Kingdom - recruitingPHASE1, PHASE2
A Study Assessing HMB-002 in Participants With Von Willebrand Disease
This study is testing a new medicine, HMB-002, for people with Von Willebrand Disease (VWD). It's looking at how safe it is, how the body uses it, and if it helps reduce bleeding. It's for adults aged 18-64.
United States · Australia · United Kingdom - recruitingPHASE3
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
This study looks at a new medicine called Vonicog Alfa for children with severe Von Willebrand Disease (VWD). It checks if this medicine can help prevent bleeding events in children who have previously used other VWD treatments.
United States · France · Ireland - recruitingNA
Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease
This study looks at new ways to prevent serious bleeding in people with Von Willebrand Disease. It compares a special management plan to standard care, focusing on stomach and nosebleeds, to see which works best.
France